Replies to post #81330 on PharmaCyte Biotech Inc (PMCB)

[TBonePickems]

I agree. I'm also expecting the dreaded "Phase2b IND delayed due to trial redesign" announcement.

If that happens, I am going to call complete BS on this. How much time have we already spent designing, redesigning, re-redesigning a Phase2b trial??? I'm going to guesstimate 1-2 years. Just dig out the design we took into the FDA pre-IND...that's what we walked into that meeting with. Remember, Hidalgo, Lohr and Von Hoff were involved in that Phase 2b design... So, imo, if they come out with that excuse (and i'm expecting it), then it is nothing but the latest fabricated way to drag it out, diluting the hell out of this to raise money for their ongoing huge salaries. Remember, they get paid as this goes along, while we indirectly lose value.